BioCentury
PODCAST | Product Development

ASH Monday, Biden’s picks & vaccine conundrums: a BioCentury podcast

December 8, 2020 2:06 AM UTC

Bispecific antibodies are top of mind at this year’s ASH meeting as they start to venture into new targets and indications in the clinic. On the latest edition of the BioCentury This Week podcast, BioCentury editors discuss the trends they are seeing in data emerging from the annual American Society of Hematology meeting. They also dig into President-elect Joe Biden’s top picks for healthcare posts, how trade groups are trying to stymie the Trump administration’s latest drug pricing policy, and the critical questions to address to ensure a successful rollout of COVID-19 vaccines.   

With bispecifics easier to manufacture and deliver than cell therapies, interest in the group has been steadily growing at major medical conferences in recent years — and this year marks a turning point, says Senior Editor Lauren Martz...